68 FR 165 pgs. 51281-51282 - National Cancer Institute; Notice of Meeting
Type: NOTICEVolume: 68Number: 165Pages: 51281 - 51282
FR document: [FR Doc. 03-21692 Filed 8-25-03; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: National Institutes of Health
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the National Cancer Advisory Board.
The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the contact person listed below in advance of the meeting.
A portion of the meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4), and 552b(c)(6), as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Advisory Board, Subcommittee on Planning and Budget.
Closed: September 8, 2003, 7 p.m. to 8:30 p.m.
Agenda: The subcommittee will be establishing a funding policy for scoring large unfunded R01 grants applications.
Place: Bethesda Hyatt Hotel, 1 Metro Place, Bethesda, MD 20892.
Contact Person: Ms. Kathie Reed, Acting Executive Secretary, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 31, Room 11A03, Bethesda, MD 20892. (301) 496-5515.
Name of Committee: National Cancer Advisory Board.
Open: September 9, 2003, 8:30 a.m. to 4:20 p.m.
Agenda: Program reports and presentations; business of the Board.
Place: National Cancer Institute, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
Contact Person: Dr. Paulette S. Gray, Executive Secretary, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, 8th Floor, Room 8141, Bethesda, MD 20892-8327. (301) 496-4218.
Name of Committee: National Cancer Advisory Board.
Closed: September 9, 2003, 4:20 p.m. to recess.
Agenda: Review of grant applications.
Contact Person: Dr. Paulette S. Gray, Executive Secretary, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, 8th Floor, Room 8141, Bethesda, MD 20892-8327. (301) 496-4218.
Name of Committee: National Cancer Advisory Board.
Open: September 10, 2003, 8:30 a.m. to adjournment.
Agenda: Program reports and presentations; business of the Board.
Contact Person: Dr. Paulette S. Gray, Executive Secretary, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, 8th Floor, Room 8141, Bethesda, MD 20892-8327. (301) 496-4218.
This notice is being published less than 15 days prior to the meeting due to scheduling conflicts.
Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.
Information is also available on the Institute's/Center's home page: deainfo.nci.nih.gov/advisory/ncab.htm , where an agenda and any additional information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93,398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS.)
Dated: August 19, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-21692 Filed 8-25-03; 8:45 am]
BILLING CODE 4140-01-M